Tranexamic Acid CAS NO.1197-18-8

hebei yanxi chemical  co., LTD who registered capital of 10 million yuan, nearly to $2 million, we have a pharmaceutical raw materials factory production of pharmaceutical raw materials, and a reagent r&d center, and we do research and development production of reagent tens of thousands of species. our aim is quality strives for the survival. Seek development by credit reputation. Our products have big price advantage in Europe South America and so on .and Our company also has the advantage of high quality in Africa. in the past two years our products has reached more than 30 countries in the world, Europe. South America. North America, southeast Asia, Africa, etc. We welcome all over the world with the best quality and lowest price friend common cooperation and common development!

1:Safe shipping (TNT;EMS;FEDEX;DHL;UPS;EUB)

2:Safe payment(Btc;MoneyGram;WU)

3:Safe packing (Paraffin coating; Double aluminum foil bag; Vacuum packaging)

4:Fast delivery (3-10 DAYS fast home delivery service )

5:Best quality (Without any doping, all products are pure)

6:Safety guarantee (we do this business long time ,we know how to disguise let the product through customs)

8:New international transportation system(Pls see the pic,The transportation line reaches every corner of the world)

9:Huge Supply(We have many raw materials and processing centers,Each day can provide dozens of kilogram-hundreds of kilograms of different products.)

10:Low Price(All the products are factory prices it can let you have a bigger profit margin)

1.lowest price 

2.good service

3.best quality 

4.rich experience 

5.support sample

Purpose:
Tranexamic acid, a synthetic derivative of lysine, is an antifibrinolytic drug with hemostatic properties. Tranaminocyclic acid can strongly adsorb lysine-binding sites (LBS) of fibrin affinity sites on plasminase and plasminogen, and inhibit the binding of plasminogen and fibrin, thus strongly inhibiting the fibrin decomposition caused by plasminogen. In addition, the anti-fibrinolytic effect of tranatemic acid was more obvious in the presence of anti-fibrinolytic enzymes such as macroglobulin in serum. It has a bioavailability of 34% and a half-life of 3.1h.